Stuart K Calderwood Selected Research

Vaccines

1/2023	A Novel Heat Shock Protein 70-Based Vaccine Prepared from DC Tumor Fusion Cells: An Update.
1/2018	A Novel Heat Shock Protein 70-based Vaccine Prepared from DC-Tumor Fusion Cells.
12/2014	Hsp90-peptide complexes stimulate antigen presentation through the class II pathway after binding scavenger receptor SREC-I.
8/2013	Cellular and molecular chaperone fusion vaccines: targeting resistant cancer cell populations.
7/2013	Immunotherapy of radioresistant mammary tumors with early metastasis using molecular chaperone vaccines combined with ionizing radiation.
1/2012	Heat shock proteins, autoimmunity, and cancer treatment.
11/2011	Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come.
1/2011	Preparation of a heat-shock protein 70-based vaccine from DC-tumor fusion cells.
1/2010	A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use.
9/2008	Cell fusion: from hybridoma to dendritic cell-based vaccine.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stuart K Calderwood Research Topics

Disease

67	Neoplasms (Cancer) 05/2024 - 11/2002
12	Carcinogenesis 04/2020 - 01/2005
8	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2005
8	Carcinoma (Carcinomatosis) 04/2015 - 07/2004
7	Breast Neoplasms (Breast Cancer) 05/2024 - 01/2005
6	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 12/2007
4	Inflammation (Inflammations) 11/2015 - 02/2005
4	Hyperthermia 08/2013 - 12/2005
3	Squamous Cell Carcinoma of Head and Neck 05/2020 - 10/2018
3	Ovarian Neoplasms (Ovarian Cancer) 08/2013 - 01/2010
3	Necrosis 11/2009 - 07/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2021
2	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2021 - 01/2016
2	Mouth Neoplasms (Oral Cancer) 05/2020 - 11/2018
2	Shock 01/2009 - 04/2002
2	Melanoma (Melanoma, Malignant) 12/2007 - 11/2002
2	Wounds and Injuries (Trauma) 10/2007 - 07/2007
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2023
1	Sarcoma (Soft Tissue Sarcoma) 03/2023
1	Adenocarcinoma of Lung 03/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2023
1	Lymphatic Metastasis 12/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2022
1	Circulating Neoplastic Cells 02/2020
1	Chronic Disease (Chronic Diseases) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Adenocarcinoma 01/2018
1	Genomic Instability 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Hypoxia (Hypoxemia) 01/2016
1	Virus Diseases (Viral Diseases) 06/2015
1	Sarcopenia 05/2012

Drug/Important Bio-Agent (IBA)

44	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2023 - 04/2002
22	Molecular Chaperones (Chaperone, Molecular)IBA 01/2023 - 01/2005
20	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2006
15	Peptides (Polypeptides)IBA 01/2023 - 11/2002
14	VaccinesIBA 01/2023 - 01/2005
10	AntigensIBA 04/2012 - 09/2005
8	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2020 - 11/2002
7	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 02/2005
6	Cancer VaccinesIBA 01/2023 - 11/2006
5	Transcription Factors (Transcription Factor)IBA 03/2023 - 09/2014
5	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 12/2006
4	Heat Shock Transcription FactorsIBA 04/2012 - 04/2002
3	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2005
3	Messenger RNA (mRNA)IBA 05/2024 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2005
2	HSP72 Heat-Shock ProteinsIBA 05/2024 - 05/2012
2	Phosphotransferases (Kinase)IBA 10/2021 - 01/2008
2	Trans-Activators (Trans-Acting Factor)IBA 04/2020 - 02/2020
2	Matrix Metalloproteinases (MMPs)IBA 04/2020 - 01/2017
2	CateninsIBA 02/2020 - 04/2015
2	ProteomeIBA 01/2020 - 01/2011
2	Cetuximab (Erbitux)FDA Link 11/2018 - 10/2018
2	ErbB Receptors (EGF Receptor)IBA 11/2018 - 10/2018
2	LigandsIBA 01/2018 - 09/2005
2	Complement System Proteins (Complement)IBA 07/2013 - 01/2010
2	Mutant Proteins (Protein, Mutant)IBA 01/2013 - 04/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2024
1	VimentinIBA 12/2022
1	HeterochromatinIBA 12/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	ArsenicIBA 12/2021
1	Arsenicals (Arsenic Compounds)IBA 12/2021
1	Arsenic Trioxide (Trisenox)FDA Link 12/2021
1	Small Interfering RNA (siRNA)IBA 05/2020
1	Epithelial Cell Adhesion MoleculeIBA 05/2020
1	Metalloproteases (Metalloproteinases)IBA 04/2020
1	Benztropine (Benzatropine)FDA LinkGeneric 02/2020
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2020
1	1-(2 (diphenylmethoxy)ethyl)- 4- (3- phenylpropyl)piperazineIBA 02/2020
1	ZincIBA 06/2019
1	Epidermal Growth Factor (EGF)IBA 10/2018
1	LipidsIBA 01/2018
1	CholesterolIBA 01/2018
1	Cell Adhesion MoleculesIBA 01/2018
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2018
1	DNA-Activated Protein KinaseIBA 01/2016
1	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 01/2016
1	EnzymesIBA 01/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 11/2015
1	Co-Repressor ProteinsIBA 10/2015
1	Pathogen-Associated Molecular Pattern MoleculesIBA 06/2015
1	Double-Stranded RNA (RNA, Double Stranded)IBA 06/2015
1	Toll-Like Receptor 4IBA 01/2015
1	Scavenger Receptors (Scavenger Receptor)IBA 12/2014
1	N-(3-pyridylmethyl)adriamycin (YM 1)IBA 09/2014
1	SurvivinIBA 09/2014
1	Combined VaccinesIBA 07/2013
1	Pyridinolcarbamate (P23)IBA 01/2013
1	ORALIT (ORS)IBA 05/2012
1	Hemoglobins (Hemoglobin)IBA 05/2012

Therapy/Procedure

25	Therapeutics 01/2022 - 01/2005
12	Immunotherapy 07/2013 - 11/2002
4	Drug Therapy (Chemotherapy) 10/2011 - 01/2005
2	Castration 01/2020 - 01/2020
2	Radiotherapy 07/2013 - 01/2010
1	Precision Medicine 01/2020
1	Transplantation 01/2018